Skip to main content

Month: August 2020

REMINDER – KP Tissue to Release its Financial Results and those of Kruger Products L.P. for the Second Quarter of 2020

MISSISSAUGA, Ontario, Aug. 05, 2020 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX:KPT), which holds a limited partnership interest in Kruger Products L.P. (“KPLP”), will release the financial results for KPT and KPLP for the second quarter of 2020 on Thursday, August 6, 2020 before the market opens. KPT will hold its conference call the same day at 8:30 a.m.  Eastern Time.Details of the Conference CallVia telephone: 1- 877-223-4471 or 647-788-4922Via the internet at: www.kptissueinc.comPresentation material referenced during the conference call will be available at www.kptissueinc.com.Conference Call RebroadcastA rebroadcast of the conference call will be available until midnight, August 13, 2020 by dialing 1-800-585-8367 or 416-621-4642 and entering passcode­­ 1935229.The replay of the webcast will remain available on the web...

Continue reading

RAPPEL – Papiers Tissu KP publiera ses résultats financiers et ceux de Produits Kruger S.E.C. pour le deuxième trimestre de l’exercice 2020

MISSISSAUGA, Ontario, 05 août 2020 (GLOBE NEWSWIRE) — Papiers Tissu KP inc. (TSX : KPT) (« PTKP »), qui détient un intérêt limité dans Produits Kruger S.E.C (« PK S.E.C. »), publiera les résultats financiers de PTKP et de PK S.E.C. pour le deuxième trimestre de l’exercice 2020 le jeudi 6 août 2020, avant l’ouverture de la séance. PTKP tiendra une téléconférence cette même journée, à 8 h 30, heure de l’Est.Renseignements sur la téléconférence (en anglais seulement)Au téléphone : 1- 877-223-4471 ou 647-788-4922Sur le site Web : www.kptissueinc.comLes documents auxquels on fera référence lors de la téléconférence seront disponibles au www.kptissueinc.com.Téléconférence archivéeLa téléconférence sera disponible jusqu’à minuit le 13 août 2020 et il sera possible d’y accéder en composant le 1-800-585-8367 ou le 416-621-4642 et en...

Continue reading

Option Care Health to Participate in the Canaccord Genuity Virtual Growth Conference

BANNOCKBURN, Ill., Aug. 05, 2020 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the 40th Annual Canaccord Genuity Virtual Growth Conference on Wednesday, August 12, 2020. John Rademacher, Option Care Health’s Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, are scheduled to present at 10:00 a.m. EST. A live audio webcast and replay of this presentation will be available at https://investors.optioncarehealth.com.About Option Care HealthOption Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 5,000 teammates including approximately 2,900 clinicians, we work compassionately to elevate standards of care for...

Continue reading

AgEagle Aerial Systems to Host Corporate Update on Tuesday, August 18, 2020 at 11:00 AM ET

NEODESHA, Kan., Aug. 05, 2020 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS), an industry leading provider of UAVs and advanced aerial imagery, data collection and analytics solutions, will host a webcast on Tuesday, August 18, 2020 at 11:00 a.m. Eastern time to provide a corporate update and discuss recent operational highlights.AgEagle CEO Michael Drozd and CFO Nicole Fernandez-McGovern will host the conference call. Investors and analysts are encouraged to submit questions they would like management to address during the discussion via email to UAVS@gatewayir.com by Friday, August 14, 2020 at 5:00 p.m. Eastern time.Webcast Date: Tuesday, August 18, 2020Time: 11:00 a.m. Eastern time (10:00 a.m. Central time)Webcast Link: https://www.webcaster4.com/Webcast/Page/2160/36280The corporate update will be broadcast...

Continue reading

Yield10 Bioscience Announces Spring Planting of 50 Acres of Wild-Type Spring Camelina to Support Business Development Plans

WOBURN, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it established 50 acres of spring Camelina under contract with a grower in Montana in the second quarter of 2020. This is a business development activity necessary to gain experience in establishing the value chain for producing Camelina sativa seed at large scale as a source of new crop products. The objective of this activity was to gain experience in seed bulk-up, grower contracts, logistics and handling of harvested seed, including toll crushing, and to produce quantities of oil and protein meal for customer sampling. The crop has reached maturity and is currently drying down with harvesting expected in the weeks ahead.“The successful establishment of spring Camelina at the 50 acre...

Continue reading

red violet Introduces Geospatial Search and Information Retrieval Technology Within Leading idiCORE Investigative Platform

BOCA RATON, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced the beta release of its geospatial search and information retrieval technology, available only through the idiCORE™ platform of red violet subsidiary Interactive Data, LLC (IDI).By combining geohash indexing with wild card and feature filtering techniques, the technology enables users to leverage data in new and insightful ways. Powerful cross-linking of entities in IDI’s massive data repository enables efficient exploration of people, businesses, assets, and interrelationships, delivering greater and otherwise unattainable intelligence, including advanced understanding of both current and historical geographic relationships.Initially applied to IDI’s comprehensive motor vehicle...

Continue reading

Nicholas Financial, Inc. Announces New Company Logo and 35th Anniversary

CLEARWATER, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) — Nicholas Financial, Inc. (NASDAQ: NICK) – an industry leading branch-based subprime auto lender focused on servicing the needs of the local independent dealer and borrowing customer – announced the launch of their new company logo.  The refreshed image reflects Nicholas’ current renaissance and symbolizes its focus on the future as it proudly celebrates its 35th Anniversary.“We are excited to unveil our new logo and retire the world map logo that has represented our brand since 1985,” said Doug Marohn, president and CEO of Nicholas Financial.  “A more modern, streamlined logo is just one small example of our renewed commitment to improvement, success and excellence.”After careful consideration, the Company chose a new logo that reflects a more modern look and captures its mission...

Continue reading

Entera Bio to Present at BTIG’s Virtual Biotechnology Conference

BOSTON and JERUSALEM, Aug. 05, 2020 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its management team will participate virtually in the BTIG Biotechnology Conference on Monday, August 10, 2020 at 12:30 p.m. EDT. To access a live webcast of the fireside chat on the “Investor Relations” page of Entera’s website, please click here. A replay of the webcast will be archived on Entera’s website for approximately 45 days following the presentation.About Entera BioEntera is a leader in the development of orally delivered macromolecule therapeutics for use in areas with significant unmet medical need where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company’s proprietary,...

Continue reading

Allena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update

— Expanding URIROX-2 Trial Sites; Interim Analysis on Track for the First Quarter of 2022 –-— Initiated Phase 1 Clinical Trial of ALLN-346; Initial Data Expected in the Fourth Quarter of 2020 –-— Raised Gross Proceeds of $22.7M Through Two Public Offerings, Extending Cash Runway Beyond the Second Quarter of 2021 –-NEWTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today reported financial results for the second quarter ended June 30, 2020 and provided a business update.“In concert with our recent financings, our team has moved quickly to implement planned activities across our portfolio,...

Continue reading

Vericel Reports Second Quarter 2020 Financial Results

Product Revenues of $20.0 Million Reported for the Second QuarterConference Call Today at 8:30am Eastern TimeCAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the second quarter ended June 30, 2020.Total net product revenues of $20.0 million, compared to $26.2 million in the second quarter of 2019;MACI® net revenue of $15.1 million and Epicel® net revenue of $4.9 million;Gross margin of 57%, compared to gross margin of 66% in the second quarter of 2019;Net loss of $8.3 million, or $0.18 per share, compared to $19.8 million, or $0.45 per share, in the second quarter of 2019, which included the $17.5 million upfront license payment to MediWound Ltd. for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.